News Features A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts Shelley Wood July 07, 2022
News Features Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle Shelley Wood October 08, 2021
News Features Low Numbers and ‘Anecdata’: Shoddy Research Rode COVID-19’s First Wave Michael O'Riordan January 11, 2021
News Features Obesity and COVID-19: Theories and Blame Fill the Scientific Void Shelley Wood April 21, 2020
News Features The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine Shelley Wood October 22, 2018
News Features Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate Michael O'Riordan November 27, 2017
News Features Be It Resolved: As Evidence Mounts in Favor of a Brain-Heart Connection, Stress Should Be on the Radar During CVD Diagnosis Yael L. Maxwell January 16, 2017
News Features Sodium Wars: Where Some See Linear Link With All-Cause Death, Others See No Need to Change Western Ways Michael O'Riordan October 05, 2016
News Features Requiem for a Heavyweight: Big Brand Statin Era Comes to a Close as Crestor Heads Off-Patent Michael O'Riordan May 03, 2016
News Features Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold Michael O'Riordan January 06, 2016